Search for: "Martin v. Bayer Healthcare Pharmaceuticals, Inc."
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
11 Feb 2015, 12:23 pm
Anyway, it is with great pleasure that the IPKat and Merpel welcome Marty has a guest contributor with the following item [Merpel calls it a "Marticle"] on a recent US District Court for the Eastern District of Virginia ruling, Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), accessible here. [read post]
5 Jul 2013, 5:00 am
” Martin v. [read post]
20 Mar 2009, 2:05 am
Lederle Laboratories, 732 P.2d 297, 306-07 (Idaho 1987).Illinois: Martin v. [read post]
16 Feb 2015, 1:44 am
* Bayer feels the pain: branded Naproxen can't invoke the territoriality principleKatfriend Marty Schwimmer reports on Belmora LLC v Bayer Consumer Care AG and Bayer Healthcare LLC, 1:14-cv-00847-GBL (EDVA Feb. 6, 2015), a recent US District Court for the Eastern District of Virginia ruling that deals with Article 6bis of the Paris Convention in the US as it applies to Bayer’s trade mark ‘FLANAX’. [read post]
2 Jun 2011, 12:46 pm
Baxter Healthcare Corp., 764 N.E.2d 35, 42 (Ill. 2002) (applied to medical device); Martin v. [read post]
23 Jun 2014, 12:57 pm
Ortho Pharmaceutical Corp., 788 F. 2d 741, 744–745 (11th Cir. 1986). [read post]
9 Aug 2012, 5:00 am
TMC Healthcare, 2006 WL 3257121 (vascular device) Deposition2006-04-04 Grother v. [read post]
2 Mar 2012, 6:52 am
TMC Healthcare, 2006 WL 3257121 (vascular device) Deposition2006-04-04 Grother v. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
